To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Comparing clinical scores and secondary surgery rate between MSC injection vs TKA for secondary OA

Download
Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Author Verified
Ace Report Cover
May 2019

Comparing clinical scores and secondary surgery rate between MSC injection vs TKA for secondary OA

Vol: 8| Issue: 5| Number:21| ISSN#: 2564-2537
Study Type:Randomized Trial
OE Level Evidence:2
Journal Level of Evidence:N/A

Subchondral stem cell therapy versus contralateral total knee arthroplasty for osteoarthritis following secondary osteonecrosis of the knee

Int Orthop. 2018 Nov;42(11):2563-2571. doi: 10.1007/s00264-018-3916-9

Contributing Authors:
P Hernigou JC Auregan CH Flouzat Lachaniette A Dubory N Chevallier H Rouard

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

60 patients with bilateral secondary knee osteoarthritis to corticosteroid-induced osteonecrosis were randomized to have one knee treated with subchondral injection of mesenchymal stem cells, and one knee treated with total knee arthroplasty. Patients were assessed over a minimum of 8 years after treatment. Results demonstrated no significant difference between groups in outcome on the Knee Societ...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue